Top

The European Journal of Health Economics

Published in:

Open Access 01-03-2019 | Original Paper

Design and effects of outcome-based payment models in healthcare: a systematic review

Authors: F. P. Vlaanderen, M. A. Tanke, B. R. Bloem, M. J. Faber, F. Eijkenaar, F. T. Schut, P. P. T. Jeurissen

Published in: The European Journal of Health Economics | Issue 2/2019

Abstract

Introduction

Outcome-based payment models (OBPMs) might solve the shortcomings of fee-for-service or diagnostic-related group (DRG) models using financial incentives based on outcome indicators of the provided care. This review provides an analysis of the characteristics and effectiveness of OBPMs, to determine which models lead to favourable effects.

Methods

We first developed a definition for OBPMs. Next, we searched four data sources to identify the models: (1) scientific literature databases; (2) websites of relevant governmental and scientific agencies; (3) the reference lists of included articles; (4) experts in the field. We only selected studies that examined the impact of the payment model on quality and/or costs. A narrative evidence synthesis was used to link specific design features to effects on quality of care or healthcare costs.

Results

We included 88 articles, describing 12 OBPMs. We identified two groups of models based on differences in design features: narrow OBPMs (financial incentives based on quality indicators) and broad OBPMs (combination of global budgets, risk sharing, and financial incentives based on quality indicators). Most (5 out of 9) of the narrow OBPMs showed positive effects on quality; the others had mixed (2) or negative (2) effects. The effects of narrow OBPMs on healthcare utilization or costs, however, were unfavourable (3) or unknown (6). All broad OBPMs (3) showed positive effects on quality of care, while reducing healthcare cost growth.

Discussion

Although strong empirical evidence on the effects of OBPMs on healthcare quality, utilization, and costs is limited, our findings suggest that broad OBPMs may be preferred over narrow OBPMs.

Available only for authorised users

Orszag, P.R., Ellis, P.: The challenge of rising health care costs. A view from the Congressional Budget Office. N. Engl. J. Med. 357(18), 1793–1795 (2007). https://doi.org/10.1056/NEJMp078190 PubMedCrossRef

Tai, W., Kalanithi, L., Milstein, A.: What can be achieved by redesigning stroke care for value-based world? Expert Rev. Pharmacoecon. Outcomes Res. 14(5), 585–587 (2014)PubMedCrossRef

Nicholson, S., Pauly, M.V., Wu, A.Y., Murray, J.F., Teutsch, S.M., Berger, M.L.: Getting real performance out of pay-for-performance. Milbank Q. 86(3), 435–457 (2008). https://doi.org/10.1111/j.1468-0009.2008.00528.x PubMedPubMedCentralCrossRef

Eijkenaar, F., Emmert, M., Scheppach, M., Schoffski, O.: Effects of pay for performance in health care: a systematic review of systematic reviews. Health Policy. 110(2–3), 115–130 (2013). https://doi.org/10.1016/j.healthpol.2013.01.008 PubMedCrossRef

Milstein, R., Schreyoegg, J.: Pay for performance in the inpatient sector: a review of 34 P4P programs in 14 OECD countries. Health Policy 120(10), 1125–1140 (2016)PubMedCrossRef

Ryan, A.M., Nallamothu, B.K., Dimick, J.B.: Medicare’s public reporting initiative on hospital quality had modest or no impact on mortality from three key conditions. Health Aff. (Millwood) 31(3), 585–592 (2012)CrossRef

Roland, M., Campbell, S.: Successes and failures of pay for performance in the United Kingdom. N. Engl. J. Med. 370(20), 1944–1949 (2014)PubMedCrossRef

Conrad, D.A., Perry, L.: Quality-based financial incentives in health care: can we improve quality by paying for it? Annu. Rev. Public Health 30, 357–371 (2009)PubMedCrossRef

Eijkenaar, F., Schut, F.T.: Uitkomstbekostiging in de zorg: een (on)begaanbare weg?. Institute of Health Policy and Management, Rotterdam (2015)

10.

Eijkenaar, F.: Key issues in the design of pay for performance programs. Eur. J. Health Econ. 14(1), 117–131 (2013)PubMedCrossRef

11.

Jha, A.K.: Time to get serious about pay for performance. JAMA 309(4), 347–348 (2013)PubMedCrossRef

12.

Mehrotra, A., Sorbero, M.E., Damberg, C.L.: Using the lessons of behavioral economics to design more effective pay-for-performance programs. Am. J. Manag. Care 16(7), 497–503 (2010)PubMedPubMedCentral

13.

Rosenthal, M.B., Dudley, R.A.: Pay-for-performance: will the latest payment trend improve care? JAMA 297(7), 740–744 (2007)PubMedCrossRef

14.

Werner, R.M., Dudley, R.A.: Making the ‘pay’ matter in pay-for-performance: implications for payment strategies. Health Aff (Millwood) 28(5), 1498–1508 (2009)CrossRef

15.

Roland, M.: Pay-for-performance: not a magic bullet. Ann. Intern. Med. 157(12), 912–913 (2012)PubMedCrossRef

16.

Eijkenaar, F., van de Ven, W., Schut, F.T.: Uitkomstbekostiging in de zorg: internationale voorbeelden en relevantie voor Nederland. Institute for Health Policy and Management, Rotterdam (2012)

17.

Hayen, A.P., de Bekker, P.J.G.M., Ouwens, M.M.T.J., Westert, G.P., Jeurissen, P.P.T.: No cure, no pay? The road to outcome-based payments in Dutch healthcare; current situation and opportunities. Celsus Academy for Sustainable Care, Nijmegen (2013)

18.

Eijkenaar, F.: Pay for performance in health care: an international overview of initiatives. Med. Care Res. Rev. 69(3), 251–276 (2012). https://doi.org/10.1177/1077558711432891 PubMedCrossRef

19.

Donabedian, A.: The quality of care: how can it be assessed? JAMA 260(12), 1743–1748 (1988)PubMedCrossRef

20.

(OECD): OECD Health Statistics 2014: Definitions, Sources and Methods Health Expenditure and Financing. Organisation for Economic Co-operation and Development, Paris (2014)

21.

(OECD): Country Classification 2011. Organisation for Economic Co-operation and Development, Paris (2011). http://www.oecd.org/tad/xcred/48405330.pdf. Accessed 4 Jul 2018

22.

Downs, S.H., Black, N.: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health 52, 377–384 (1998)PubMedPubMedCentralCrossRef

23.

(CASP): CASP Qualitative Checklist (2017). http://www.casp-uk.net/casp-tools-checklists. Accessed 4 Jul 2018

24.

(CASP): CASP Systematic Review Checklist (2017). http://www.casp-uk.net/casp-tools-checklists. Accessed 4 Jul 2018

25.

van Herck, P., de Smedt, D., Annemans, L., Remmen, R., Rosenthal, M.B., Sermeus, W.: Systematic review: effects, design choices, and context of pay-for-performance in health care. BMC Health Serv. Res. 10, 247 (2010)PubMedPubMedCentralCrossRef

26.

Gillam, S.J., Siriwardena, A.N., Steel, N.: Pay-for-performance in the United Kingdom: impact of the quality and outcomes framework: a systematic review. Ann. Family Med. 10(5), 461–468 (2012)CrossRef

27.

Song, Z., Safran, D.G., Landon, B.E., He, Y., Ellis, R.P., Mechanic, R.E., Day, M.P., Chernew, M.E.: Health care spending and quality in year 1 of the alternative quality contract. N. Engl. J. Med. 365(10), 909–918 (2011)PubMedPubMedCentralCrossRef

28.

Song, Z., Safran, D.G., Landon, B.E., Landrum, M.B., He, Y., Mechanic, R.E., Day, M.P., Chernew, M.E.: The ‘alternative quality contract,’ based on a global budget, lowered medical spending and improved quality. Health Aff. 31(8), 1885–1894 (2012)CrossRef

29.

McDonald, R., Kristensen, S.R., Zaidi, S., Sutton, M., Todd, S., Konteh, F., Hussein, K., Brown, S.: Evaluation of the Commissioning for Quality and Innovation Framework. University of Nottingham (2013)

30.

Bhattacharyya, T., Mehta, P., Freiberg, A.A.: Hospital characteristics associated with success in a pay-for-performance program in orthopaedic surgery. J. Bone Jt. Surg. 90(6), 1240–1243 (2008)CrossRef

31.

Epstein, A.M., Jha, A.K., Orav, E.J.: The impact of pay-for-performance on quality of care for minority patients. Am. J. Manag. Care 20(10), 479–486 (2014)

32.

Kahn, C.N., Ault, T., Potetz, L., Walke, T., Chambers, J.H., Burch, S.: Assessing Medicare’s hospital pay-for-performance programs and whether they are achieving their goals. Health Aff. 34(8), 1281–1288 (2015). https://doi.org/10.1377/hlthaff.2015.0158 CrossRef

33.

Mellor, J., Daly, M., Smith, M.: Does it pay to penalize hospitals for excess readmissions? Intended and unintended consequences of medicare’s hospital readmissions reductions program. Health Econ. 15, 1037–1051 (2016). https://doi.org/10.1002/hec.3382 CrossRef

34.

Chien, A.T., Eastman, D., Li, Z., Rosenthal, M.B.: Impact of a pay for performance program to improve diabetes care in the safety net. Prev. Med. 55, S80–S85 (2012)PubMedCrossRef

35.

Calikoglu, S., Murray, R., Feeney, D.: Hospital pay-for-performance programs in Maryland produced strong results, including reduced hospital-acquired conditions. Health Aff. 31(12), 2649–2658 (2012)CrossRef

36.

(CMS): Table 33: ACO Quality Measures. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/ACO-Shared-Savings-Program-Quality-Measures.pdf (2016). Accessed 8 Feb 2017

37.

Chung, S., Palaniappan, L., Wong, E., Rubin, H., Luft, H.: Does the frequency of pay-for-performance payment matter? Experience from a randomized trial. Health Serv. Res. 45(2), 553–564 (2010). https://doi.org/10.1111/j.1475-6773.2009.01072.x PubMedPubMedCentralCrossRef

38.

Chung, S., Palaniappan, L.P., Trujillo, L.M., Rubin, H.R., Luft, H.S.: Effect of physician-specific pay-for-performance incentives in a large group practice. Am. J. Manag. Care 16(2), 35–42 (2010)

39.

Campbell, S.M., McDonald, R., Lester, H.: The experience of pay for performance in english family practice: a qualitative study. Ann. Fam. Med. 6(3), 228–234 (2008)PubMedPubMedCentralCrossRef

40.

Doran, T., Fullwood, C., Gravelle, H., Reeves, D., Kontopantelis, E., Hiroeh, U., Roland, M.: Pay-for-performance programs in family practices in the United Kingdom. N. Engl. J. Med. 355(4), 375–384 (2006)PubMedCrossRef

41.

Doran, T., Fullwood, C., Kontopantelis, E., Reeves, D.: Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework. Lancet 372(9640), 728–736 (2008)PubMedCrossRef

42.

Doran, T., Kontopantelis, E., Valderas, J.M., Campbell, S., Roland, M., Salisbury, C., Reeves, D.: Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework. BMJ 343(7814) (2011)

43.

(HSCIC): QOF Indicator Definitions 2014–15. Health and Social Care Information Centre, Leeds (2014)

44.

(CMS): Hospital Value-Based Purchasing Fact Sheet (2017). https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/Downloads/Hospital_VBPurchasing_Fact_Sheet_ICN907664.pdf. Accessed 10 Apr 2018

45.

Kim, S.M., Jang, W.M., Ahn, H.A., Park, H.J., Ahn, H.S.: Korean National Health Insurance Value Incentive Program: achievements and future directions. J. Prev. Med. Public Health 45(3), 148–155 (2012)PubMedPubMedCentralCrossRef

46.

Yang, J.H., Kim, S.M., Han, S.J., Knaak, M., Yang, G.H., Lee, K.D., Yoo, Y.H., Ha, G., Kim, E.J., Yoo, M.S.: The impact of Value Incentive Program (VIP) on the quality of hospital care for acute stroke in Korea. Int. J. Qual. Health Care 28(5), 580–585 (2016)PubMedCrossRef

47.

Kristensen, S.R., McDonald, R., Sutton, M.: Should pay-for-performance schemes be locally designed? Evidence from the Commissioning for Quality and Innovation (CQUIN) Framework. J. Health Serv. Res. Policy 18(2), 38–49 (2013)PubMedCrossRef

48.

Song, Z., Safran, D.G., Landon, B.E., Rose, S., Day, M., Chernew, M.E.: Payment reform in Massachusetts: effect of global payment on health care spending and quality 4 years into the alternative quality contract. J. Gen. Intern. Med. 29, S169 (2014)CrossRef

49.

Barry, C.L., Stuart, E.A., Donohue, J.M., Greenfield, S.F., Kouri, E., Duckworth, K., Song, Z., Mechanic, R.E., Chernew, M.E., Huskamp, H.A.: The early impact of the ‘alternative quality contract’ on mental health service use and spending in Massachusetts. Health Aff. (Proj. Hope) 34(12), 2077–2085 (2015). https://doi.org/10.1377/hlthaff.2015.0685 CrossRef

50.

Chien, A.T., Song, Z., Chernew, M.E., Landon, B.E., McNeil, B.J., Safran, D.G., Schuster, M.A.: Two-year impact of the alternative quality contract on pediatric health care quality and spending. Pediatrics 133(1), 96–104 (2014)PubMedPubMedCentralCrossRef

51.

Stuart, E.A., Barry, C.L., Donohue, J.M., Greenfield, S.F., Duckworth, K., Song, Z., Mechanic, R., Kouri, E.M., Ebnesajjad, C., Chernew, M.E., Huskamp, H.A.: Effects of accountable care and payment reform on substance use disorder treatment: evidence from the initial 3 years of the alternative quality contract. Addiction 12, 124–131 (2016). https://doi.org/10.1111/add.13555 CrossRef

52.

Sharp, A.L., Song, Z., Safran, D.G., Chernew, M.E., Mark Fendrick, A.: The effect of bundled payment on emergency department use: alternative quality contract effects after year one. Acad. Emerg. Med. 20(9), 961–964 (2013)PubMedPubMedCentralCrossRef

53.

McCarthy, M.: “Value based” payment project saves US nearly $400 m in two years, report finds. BMJ 350, h2432 (2015). https://doi.org/10.1136/bmj.h2432 PubMedCrossRef

54.

Shlebak, A., Sandhu, P., Ali, V., Jones, G., Baker, C.: The impact of the DoH Commissioning for Quality and Innovation incentive on the success of venous thromboembolism risk assessment in hospitalised patients. A single institution experience in a quality outcome improvement over a 4-year cycle. JRSM Open 7(6), 2054270416632702 (2016). https://doi.org/10.1177/2054270416632702 PubMedPubMedCentralCrossRef

55.

Fleetcroft, R., Steel, N., Cookson, R., Walker, S., Howe, A.: Incentive payments are not related to expected health gain in the pay for performance scheme for UK primary care: cross-sectional analysis. BMC Health Serv. Res. 12, 94 (2012)PubMedPubMedCentralCrossRef

56.

Millett, C., Gray, J., Saxena, S., Netuveli, G., Khunti, K., Majeed, A.: Ethnic disparities in diabetes management and pay-for-performance in the UK: the Wandsworth Prospective Diabetes Study. PLoS Med. 4(6), e191 (2007)PubMedPubMedCentralCrossRef

57.

Strong, M., South, G., Carlisle, R.: The UK Quality and Outcomes Framework pay-for-performance scheme and spirometry: rewarding quality or just quantity? A cross-sectional study in Rotherham, UK. BMC Health Serv. Res. 9(108) (2009)

58.

Lee, J.Y., Lee, S.I., Kim, N.S., Kim, S.H., Son, W.S., Jo, M.W.: Healthcare organizations’ attitudes toward pay-for-performance in Korea. Health Policy 108(2–3), 277–285 (2012)PubMedCrossRef

59.

60.

Chien, A.T., Li, Z., Rosenthal, M.B.: Improving timely childhood immunizations through pay for performance in medicaid-managed care. Health Serv. Res. 45(6), 1934–1947 (2010)PubMedPubMedCentralCrossRef

61.

Gilman, M., Adams, E.K., Hockenberry, J.M., Milstein, A.S., Wilson, I.B., Becker, E.R.: Safety-net hospitals more likely than other hospitals to fare poorly under medicare’s value-based purchasing. Health Aff. 34(3), 398–405 (2015)CrossRef

62.

Figueroa, J.F., Tsugawa, Y., Zheng, J., Orav, E.J., Jha, A.K.: Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study. BMJ 353, i2214 (2016). https://doi.org/10.1136/bmj.i2214 PubMedPubMedCentralCrossRef

63.

Ryan, A.M., Burgess, J.F., Pesko, M.F., Borden, W.B., Dimick, J.B.: The early effects of Medicare’s mandatory hospital pay-for-performance program. Health Serv. Res. 50(1), 81–97 (2015)PubMedCrossRef

64.

Chee, T.T., Ryan, A.M., Wasfy, J.H., Borden, W.B.: Current state of value-based purchasing programs. Circulation 133(22), 2197–2205 (2016). https://doi.org/10.1161/circulationaha.115.010268 PubMedPubMedCentralCrossRef

65.

Mehrotra, A., Damberg, C.L., Sorbero, M.E.S., Teleki, S.S.: Pay for performance in the hospital setting: what is the state of the evidence? Am. J. Med. Qual. 24(1), 19–28 (2009)PubMedCrossRef

66.

Werner, R.M., Kolstad, J.T., Stuart, E.A., Polsky, D.: The effect of pay-for-performance in hospitals: lessons for quality improvement. Health Aff. 30(4), 690–698 (2011). https://doi.org/10.1377/hlthaff.2010.1277 CrossRef

67.

Jha, A.K., Joynt, K.E., Orav, E.J., Epstein, A.M.: The long-term effect of premier pay for performance on patient outcomes. N. Engl. J. Med. 366(17), 1606–1615 (2012)PubMedCrossRef

68.

Ryan, A.M.: Effects of the premier hospital quality incentive demonstration on medicare patient mortality and cost: quality and performance. Health Serv. Res. 44(3), 821–842 (2009)PubMedPubMedCentralCrossRef

69.

Campbell, S.M., Reeves, D., Kontopantelis, E., Sibbald, B., Roland, M.: Effects of pay for performance on the quality of primary care in England. N. Engl. J. Med. 361(4), 368–378 (2009)PubMedCrossRef

70.

Lee, J.T., Netuveli, G., Majeed, A., Millett, C.: The effects of pay for performance on disparities in stroke, hypertension, and coronary heart disease management: Interrupted time series study. PLoS One 6(12), e27236 (2011)

71.

Vaghela, P., Ashworth, M., Schofield, P., Gulliford, M.C.: Population intermediate outcomes of diabetes under pay-for-performance incentives in England from 2004 to 2008. Diabetes Care 32(3), 427–429 (2009)PubMedPubMedCentralCrossRef

72.

Millett, C., Saxena, S., Netuveli, G., Majeed, A.: Impact of pay for performance on ethnic disparities in intermediate outcomes for diabetes: a longitudinal study. Diabetes Care 32(3), 404–409 (2009)PubMedPubMedCentralCrossRef

73.

Alshamsan, R., Lee, J.T., Majeed, A., Netuveli, G., Millett, C.: Effect of a UK pay-for-performance program on ethnic disparities in diabetes outcomes: interrupted time series analysis. Ann. Fam. Med. 10(3), 228–234 (2012)PubMedPubMedCentralCrossRef

74.

Harrison, M.J., Dusheiko, M., Sutton, M., Gravelle, H., Doran, T., Roland, M.: Effect of a national primary care pay for performance scheme on emergency hospital admissions for ambulatory care sensitive conditions: controlled longitudinal study. BMJ 349, g6423 (2014). https://doi.org/10.1136/bmj.g6423 PubMedPubMedCentralCrossRef

75.

Kasteridis, P., Mason, A., Goddard, M., Jacobs, R., Santos, R., Rodriguez-Sanchez, B., McGonigal, G.: Risk of care home placement following acute hospital admission: effects of a pay-for-performance scheme for dementia. PloS One 11(5), e0155850 (2016). https://doi.org/10.1371/journal.pone.0155850 PubMedPubMedCentralCrossRef

76.

Serumaga, B., Ross-Degnan, D., Avery, A.J., Elliott, R.A., Majumdar, S.R., Zhang, F., Soumerai, S.B.: Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ 342(7792), 322 (2011)

77.

Simpson, C.R., Hannaford, P.C., Ritchie, L.D., Sheikh, A., Williams, D.: Impact of the pay-for-performance contract and the management of hypertension in Scottish primary care: a 6-year population-based repeated cross-sectional study. Br. J. Gen. Pract. 61(588), 443–451 (2011)CrossRef

78.

Ryan, A.M., Krinsky, S., Kontopantelis, E., Doran, T.: Long-term evidence for the effect of pay-for-performance in primary care on mortality in the UK: a population study. Lancet 388(10041), 268–274 (2016). https://doi.org/10.1016/s0140-6736(16)00276-2 PubMedCrossRef

79.

Ryan, A.M., Blustein, J., Doran, T., Michelow, M.D., Casalino, L.P.: The effect of phase 2 of the premier hospital quality incentive demonstration on incentive payments to hospitals caring for disadvantaged patients. Health Serv. Res. 47(4), 1418–1436 (2012)PubMedPubMedCentralCrossRef

80.

Shih, T., Dimick, J.B.: Does pay-for-performance improve surgical outcomes? Evaluation of phase 2 of the premier hospital quality incentive demonstration project. J. Surg. Res. 179(2), 677–681 (2013)

81.

Nattinger, M.C., Mueller, K., Ullrich, F., Zhu, X.: Financial performance of rural medicare ACOs. J. Rural Health. 24, 98–102 (2016). https://doi.org/10.1111/jrh.12205 CrossRef

82.

Greene, J., Hibbard, J.H., Overton, V.: Large performance incentives had the greatest impact on providers whose quality metrics were lowest at baseline. Health Aff. 34(4), 673–680 (2015). https://doi.org/10.1377/hlthaff.2014.0998 CrossRef

83.

Chatfield, J.S.: Value-based purchasing: the effect of hospital ownership and size. Health Care Manag. 35(3), 199–205 (2016). https://doi.org/10.1097/hcm.0000000000000116 CrossRef

84.

Zhao, M., Haley, D.R., Spaulding, A., Balogh, H.A.: Value-based purchasing, efficiency, and hospital performance. Health Care Manag. 34(1), 4–13 (2015). https://doi.org/10.1097/hcm.0000000000000048 CrossRef

85.

Wang, Y., O’Donnell, C.A., Mackay, D.F., Watt, G.C.M.: Practice size and quality attainment under the new GMS contract: a cross-sectional analysis. Br. J. Gen. Pract. 56(532), 830–835 (2006)PubMedPubMedCentral

86.

Ramirez, A.G., Tracci, M.C., Stukenborg, G.J., Turrentine, F.E., Kozower, B.D., Jones, R.S.: Physician-owned surgical hospitals outperform other hospitals in medicare value-based purchasing program. J. Am. Coll. Surg. 223(4), 559–567 (2016). https://doi.org/10.1016/j.jamcollsurg.2016.07.014 PubMedPubMedCentralCrossRef

87.

Millett, C., Bottle, A., Ng, A., Curcin, V., Molokhia, M., Saxena, S., Majeed, A.: Pay for perfomance and the quality of diabetes management in individuals with and without co-morbid medical conditions. J. R. Soc. Med. 102(9), 369–377 (2009)PubMedPubMedCentralCrossRef

88.

Shah, S.M., Carey, I.M., Harris, T., DeWilde, S., Cook, D.G.: Quality of chronic disease care for older people in care homes and the community in a primary care pay for performance system: retrospective study. BMJ 342(7797), 587 (2011)

89.

Karunaratne, K., Stevens, P., Irving, J., Hobbs, H., Kilbride, H., Kingston, R., Farmer, C.: The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3–5. Nephrol. Dial. Transplant. 28(8), 2107–2116 (2013)PubMedCrossRef

90.

Gallagher, N., Cardwell, C., Hughes, C., O’Reilly, D.: Increase in the pharmacological management of type 2 diabetes with pay-for-performance in primary care in the UK. Diabet. Med. 32(1), 62–68 (2014)PubMedCrossRef

91.

McWilliams, J.M., Landon, B.E., Chernew, M.E.: Changes in health care spending and quality for medicare beneficiaries associated with a commercial ACO contract. JAMA 310(8), 829–836 (2013)PubMedCrossRef

92.

Afendulis, C.C., Fendrick, A.M., Song, Z., Landon, B.E., Safran, D.G., Mechanic, R.E., Chernew, M.E.: The impact of global budgets on pharmaceutical spending and utilization: early experience from the alternative quality contract. Inquiry 51, 1–7 (2014). https://doi.org/10.1177/0046958014558716 CrossRef

93.

Chien, A.T., Schiavoni, K.H., Sprecher, E., Landon, B.E., McNeil, B.J., Chernew, M.E., Schuster, M.A.: How accountable care organizations responded to pediatric incentives in the alternative quality contract. Acad. Pediatrics. 16(2), 200–207 (2016). https://doi.org/10.1016/j.acap.2015.10.008 CrossRef

94.

Kruse, G.B., Polsky, D., Stuart, E.A., Werner, R.M.: The impact of hospital pay-for-performance on hospital and medicare costs. Health Serv. Res. 47(6), 2118–2136 (2012)PubMedPubMedCentralCrossRef

95.

Whalley, D., Gravelle, H., Sibbald, B.: Effect of the new contract on GPs’ working lives and perceptions of quality of care: a longitudinal survey. Br. J. Gen. Pract. 58(546), 8–14 (2008)PubMedPubMedCentralCrossRef

96.

Crawley, D., Ng, A., Mainous, A.G., Majeed, A., Millett, C.: Impact of pay for performance on quality of chronic disease management by social class group in England. J. R. Soc. Med. 102(3), 103–107 (2009)PubMedPubMedCentralCrossRef

97.

Millett, C., Gray, J., Saxena, S., Netuveli, G., Majeed, A.: Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes. CMAJ 176(12), 1705–1710 (2007)PubMedPubMedCentralCrossRef

98.

Millett, C., Gray, J., Bottle, A., Majeed, A.: Ethnic disparities in blood pressure management in patients with hypertension after the introduction of pay for performance. Ann. Fam. Med. 6(6), 490–496 (2008)PubMedPubMedCentralCrossRef

99.

Nicholas, L.H., Dimick, J.B., Iwashyna, T.J.: Do hospitals alter patient care effort allocations under pay-for-performance? Health Serv. Res. 46(1 PART 1), 61–81 (2011)PubMedPubMedCentralCrossRef

100.

Epstein, A.M., Joynt, K.E., Jha, A.K., Orav, E.J.: Access to coronary artery bypass graft surgery under pay for performance: evidence from the premier hospital quality incentive demonstration. Circul. Cardiovasc. Qual. Outcomes 7(5), 727–734 (2014). https://doi.org/10.1161/circoutcomes.114.001024 CrossRef

101.

Doran, T., Fullwood, C., Reeves, D., Gravelle, H., Roland, M.: Exclusion of patients from pay-for-performance targets by english physicians. N. Engl. J. Med. 359(3), 274–284 (2008)PubMedCrossRef

102.

Doran, T., Kontopantelis, E., Fullwood, C., Lester, H., Valderas, J.M., Campbell, S.: Exempting dissenting patients from pay for performance schemes: retrospective analysis of exception reporting in the UK Quality and Outcomes Framework. BMJ 344, e2405 (2012)PubMedPubMedCentralCrossRef

103.

Gravelle, H., Sutton, M., Ma, A.: Doctor behaviour under a pay for performance contract: treating, cheating and case finding? Econ. J. 120(542), F129–F156 (2010). http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291468-0297/issues

104.

McDonald, R., Roland, M.: Pay for performance in primary care in England and california: comparison of unintended consequences. Ann. Fam. Med. 7(2), 121–127 (2009)PubMedPubMedCentralCrossRef

105.

Mant, J.: Process versus outcome indicators in the assessment of quality of health care. Int. J. Qual. Health Care 13(6), 475–480 (2001)PubMedCrossRef

106.

Shakir, M., Armstrong, K., Wasfy, J.H.: Could pay-for-performance worsen health disparities? Health Policy 33(4), 567–569 (2018)

107.

Porter, M.E., Teisberg, E.O.: Redefining Health Care. Harvard Business School Press, Boston (2006)

Title: Design and effects of outcome-based payment models in healthcare: a systematic review
Authors: F. P. Vlaanderen
M. A. Tanke
B. R. Bloem
M. J. Faber
F. Eijkenaar
F. T. Schut
P. P. T. Jeurissen
Publication date: 01-03-2019
Publisher: Springer Berlin Heidelberg
Published in: The European Journal of Health Economics / Issue 2/2019
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-018-0989-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Design and effects of outcome-based payment models in healthcare: a systematic review

Abstract

Introduction

Methods

Results

Discussion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Methods

Results

Discussion

Please log in to get access to this content

Other articles of this Issue 2/2019

Structured physiotherapy including a work place intervention for patients with neck and/or back pain in primary care: an economic evaluation

When is it too expensive? Cost-effectiveness thresholds and health care decision-making

Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?

The association of potentially inappropriate medication use on health outcomes and hospital costs in community-dwelling older persons: a longitudinal 12-year study

Catastrophic financial effect of replacing informal care with formal care: a study based on haematological neoplasms

A new method for valuing health: directly eliciting personal utility functions